dr. grivas on the imvigor211 trial in metastatic urothelial carcinoma
Published 6 years ago • 125 plays • Length 2:04Download video MP4
Download video MP3
Similar videos
-
1:45
dr. grivas on unmet needs in advanced urothelial cancer
-
1:38
dr. grivas on the subgroup analyses of the javelin bladder 100 trial in advanced urothelial cancer
-
1:09
dr. grivas on the future of molecular subtyping in urothelial cancer
-
2:30
dr. grivas on parp inhibition in metastatic urothelial cancer
-
1:55
dr. grivas on investigational immunotherapy approaches in localized bladder cancer
-
2:09
petros grivas on the efficacy of sacituzumab govitecan for bladder cancer
-
1:33
dr. grivas on immunotherapy in advanced urothelial cancer
-
1:22
dr. grivas on emerging biomarkers in urothelial cancer
-
1:22
dr. grivas on immunotherapy in platinum-refractory metastatic bladder cancer
-
1:17
dr. grivas on promising combination therapies in bladder cancer
-
1:25
dr. balar on imvigor 210 results for metastatic urothelial carcinoma
-
1:56
dr. grivas on mechanisms of immune response in bladder cancer
-
2:52
pd-l1 and tmb as biomarkers in the imvigor211 trial of atezolizumab vs. chemo for bladder cancer
-
0:56
dr. grivas on the next steps for immunotherapy in bladder cancer
-
9:10
petros grivas, esmo 2019 - advances in metastatic urothelial cancer
-
0:16
imvigor 210 results in metastatic urothelial carcinoma
-
0:52
dr. davis on imvigor130 trial in metastatic urothelial cancer
-
1:47
dr. grivas on combining chemotherapy and immunotherapy in bladder cancer
-
9:22
adjuvant immunotherapy: the imvigor trials - bladder cancer video library